| Il Centro di Ricerca in Farmacologia Oculare | ||
| ☴ Prodotti della ricerca | ||
| ┅ Pittalà V, Fidilio A, Lazzara F, Platania CBM, Salerno L, Foresti R, Drago F, Bucolo C. Effects of novel nitric oxide-releasing molecules against oxidative stress on retinal pigmented epithelial cells. Oxid Med Cell Longev 2107 doi: 10.1155/2017/1420892. I.F. = 4.593 |
||
| ┅ Puglia C, Blasi P, Ostacolo C, Sommella E, *Bucolo C, Platania CBM, Romano GL, Geraci F, Drago F, Santonocito D, Albertini B, Campiglia P, Puglisi G, Pignatello R. Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery. Front Pharmacol. 2018 Mar 28;9:285. I.F. = 4.418; [*corresponding author] |
||
| ┅ Platania CBM, Fidilio A, Lazzara F, Piazza C, Geraci F, Giurdanella G, Leggio GM, Salomone S, Drago F, Bucolo C Retinal Protection and Distribution of Curcumin in Vitro and in Vivo. Front Pharmacol. 2018 Jun 22;9:670. doi: 10.3389/fphar.2018.00670. I.F. = 4.418 |
||
| ┅ Salemi R, Falzone L, Madonna G, Polesel J, Cinà D, Mallardo D, Ascierto PA, Libra M, Candido S. MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAF(V600E) Mutation Detected in Circulating-Free DNA. Front Pharmacol. 2018 Aug 14;9:856. doi: 10.3389/fphar.2018.00856. |
||
| ┅ Reibaldi M, Avitabile T, Russo A, Bonfiglio V, Mariotti C, Romano MR, Boscia F, Cennamo G, Fallico M, Parisi G, Castellino N, Bucolo C, Li Volti G, Longo A. Late-Onset Ocular Hypertension After Vitrectomy: A Multicenter Study of 6,048 Eyes. Retina. 2018 Aug 29. doi: 10.1097/IAE.0000000000002309. |
||
| ┅ Platania CBM, Leggio GM, Drago F, Salomone S, Bucolo C. Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy. Biochem Pharmacol. 2018 Sep 15;158:13-26. doi: 10.1016/j.bcp.2018.09.016. I.F. = 4.235 |
||
| ┅ Giurdanella G, Montalbano G, Gennuso F, Brancati S, Lo Furno D, Augello A, Bucolo C, Drago F, Salomone S. Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis. J Cell Physiol. 2018 Oct 14. doi: 10.1002/jcp.27545. I.F. = 3.923 |
||
| ┅ D'Amico AG, Maugeri G, Rasà D, Federico C, Saccone S, Lazzara F, Fidilio A, Drago F, Bucolo C, D'Agata V. NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage. J Cell Physiol. 2019 Apr;234(4):5230-5240. doi: 10.1002/jcp.27331. I.F. = 3.923 |
||
| ┅ Bucolo C, Gozzo L, Longo L, Mansueto S, Vitale DC, Drago F. Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies. J Pharmacol Sci. 2018 Dec;138(4):219-232. doi: 10.1016/j.jphs.2018.11.001. I.F. = 2.575 |
||
| ┅ Leggio GM, Di Marco R, Gulisano W, D'Ascenzo M, Torrisi SA, Geraci F, Lavanco G, Dahl K, Giurdanella G, Castorina A, Aitta-Aho T, Aceto G, Bucolo C, Puzzo D, Grassi C, Korpi ER, Drago F, Salomone S. Dopaminergic-GABAergic interplay and alcohol binge drinking. Pharmacol Res. 2019 Mar;141:384-391. doi: 10.1016/j.phrs.2019.01.022. I.F. = 4.408 |
||
| ┅ Trotta MC, Maisto R, Guida F, Boccella S, Luongo L, Balta C, D'Amico G, Herman H, Hermenean A, Bucolo C, D'Amico M. The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome. PLoS One. 2019 Jan 18;14(1):e0211005. doi: 10.1371/journal.pone.0211005. I.F. = 2.766 |
||
| ┅ Bucolo C, Drago F, Maisto R, Romano GL, D'Agata V, Maugeri G, Giunta S. Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway. J Cell Physiol. 2019 Feb 15. doi: 10.1002/jcp.28347. I.F. = 3.923 |
||
| ┅ Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B., Lupo G, Anfuso CD, Spandidos DA, Libra M, Candido S. Prognostic significance of deregulated microRNAs in uveal melanomas. Mol Med Rep. 2019 Feb 11. doi: 10.3892/mmr.2019.9949. I.F. = 1.922 |
||
| ┅ Platania CBM, Dei Cas M, Cianciolo S, Fidilio A, Lazzara F, Paroni R, Pignatello R, Strettoi E, Ghidoni R, Drago F, Bucolo C.* Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa. Drug Deliv. 2019 Dec;26(1):237-243. doi: 10.1080/10717544.2019.1574936. I.F. = 6.402 |
||
| ┅ Platania CBM, Maisto R, Trotta MC, D'Amico M, Rossi S, Gesualdo C, D'Amico G, Balta C, Herman H, Hermenean A, Ferraraccio F, Panarese I, Drago F, Bucolo C.* Retinal and circulating miRNA expression patterns in diabetic retinopathy: an in silico and in vivo approach. Br J Pharmacol. 2019 Mar 18. doi: 10.1111/bph.14665. I.F. = 6.81 |
||
| ┅ Patent EP3127543B1: OPHTHALMIC FORMULATIONS COMPRISING OLIGOSACCHARIDES. 1/8/2018 |
Ultima modifica:
27/03/2023 - 09:45
